Ablation of tachyarrhythmias in pediatric patients

Research output: Contribution to journalReview article

8 Citations (Scopus)

Abstract

Purpose of review: Radiofrequency (RF) ablation treatment for tachyarrhythmias has been available only for the past 15 years. The success rates have been excellent with a very low frequency of complications. Because of this efficacy, the use of RF ablation in children has become standard of care even though long-term data are unavailable. In this review, common tachyarrhythmias and their current treatments in children will be discussed. Recent findings: Novel electrophysiology technologies such as electroanatomic mapping and sophisticated ablating catheters have improved success rates and decreased complications. The improvement is also due to better understanding of the mechanisms and etiologies of tachyarrhythmias. Both have positively impacted success rates and have made more complicated tachyarrhythmias treatable with ablation. Summary: The technologic advances in ablation and improved understanding of tachyarrhythmias over the past 15 years have greatly improved outcomes in ablative treatment of tachyarrhythmias in children. In most cases this method of treatment is the preferred first-line approach to symptomatic tachyarrhythmias in children.

Original languageEnglish (US)
Pages (from-to)64-67
Number of pages4
JournalCurrent Opinion in Cardiology
Volume19
Issue number1
DOIs
StatePublished - Jan 1 2004

Fingerprint

Tachycardia
Pediatrics
Electrophysiology
Therapeutics
Standard of Care
Catheters
Technology

All Science Journal Classification (ASJC) codes

  • Cardiology and Cardiovascular Medicine

Cite this

@article{24e4919a0bce4ea7b17502c416226014,
title = "Ablation of tachyarrhythmias in pediatric patients",
abstract = "Purpose of review: Radiofrequency (RF) ablation treatment for tachyarrhythmias has been available only for the past 15 years. The success rates have been excellent with a very low frequency of complications. Because of this efficacy, the use of RF ablation in children has become standard of care even though long-term data are unavailable. In this review, common tachyarrhythmias and their current treatments in children will be discussed. Recent findings: Novel electrophysiology technologies such as electroanatomic mapping and sophisticated ablating catheters have improved success rates and decreased complications. The improvement is also due to better understanding of the mechanisms and etiologies of tachyarrhythmias. Both have positively impacted success rates and have made more complicated tachyarrhythmias treatable with ablation. Summary: The technologic advances in ablation and improved understanding of tachyarrhythmias over the past 15 years have greatly improved outcomes in ablative treatment of tachyarrhythmias in children. In most cases this method of treatment is the preferred first-line approach to symptomatic tachyarrhythmias in children.",
author = "Samii, {Soraya M.} and Cohen, {Mark H.}",
year = "2004",
month = "1",
day = "1",
doi = "10.1097/00001573-200401000-00013",
language = "English (US)",
volume = "19",
pages = "64--67",
journal = "Current Opinion in Cardiology",
issn = "0268-4705",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

Ablation of tachyarrhythmias in pediatric patients. / Samii, Soraya M.; Cohen, Mark H.

In: Current Opinion in Cardiology, Vol. 19, No. 1, 01.01.2004, p. 64-67.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Ablation of tachyarrhythmias in pediatric patients

AU - Samii, Soraya M.

AU - Cohen, Mark H.

PY - 2004/1/1

Y1 - 2004/1/1

N2 - Purpose of review: Radiofrequency (RF) ablation treatment for tachyarrhythmias has been available only for the past 15 years. The success rates have been excellent with a very low frequency of complications. Because of this efficacy, the use of RF ablation in children has become standard of care even though long-term data are unavailable. In this review, common tachyarrhythmias and their current treatments in children will be discussed. Recent findings: Novel electrophysiology technologies such as electroanatomic mapping and sophisticated ablating catheters have improved success rates and decreased complications. The improvement is also due to better understanding of the mechanisms and etiologies of tachyarrhythmias. Both have positively impacted success rates and have made more complicated tachyarrhythmias treatable with ablation. Summary: The technologic advances in ablation and improved understanding of tachyarrhythmias over the past 15 years have greatly improved outcomes in ablative treatment of tachyarrhythmias in children. In most cases this method of treatment is the preferred first-line approach to symptomatic tachyarrhythmias in children.

AB - Purpose of review: Radiofrequency (RF) ablation treatment for tachyarrhythmias has been available only for the past 15 years. The success rates have been excellent with a very low frequency of complications. Because of this efficacy, the use of RF ablation in children has become standard of care even though long-term data are unavailable. In this review, common tachyarrhythmias and their current treatments in children will be discussed. Recent findings: Novel electrophysiology technologies such as electroanatomic mapping and sophisticated ablating catheters have improved success rates and decreased complications. The improvement is also due to better understanding of the mechanisms and etiologies of tachyarrhythmias. Both have positively impacted success rates and have made more complicated tachyarrhythmias treatable with ablation. Summary: The technologic advances in ablation and improved understanding of tachyarrhythmias over the past 15 years have greatly improved outcomes in ablative treatment of tachyarrhythmias in children. In most cases this method of treatment is the preferred first-line approach to symptomatic tachyarrhythmias in children.

UR - http://www.scopus.com/inward/record.url?scp=2542483048&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=2542483048&partnerID=8YFLogxK

U2 - 10.1097/00001573-200401000-00013

DO - 10.1097/00001573-200401000-00013

M3 - Review article

C2 - 14688637

AN - SCOPUS:2542483048

VL - 19

SP - 64

EP - 67

JO - Current Opinion in Cardiology

JF - Current Opinion in Cardiology

SN - 0268-4705

IS - 1

ER -